JDD

Successful Treatment of Cheilitis Granulomatosa With Certolizumab and Ustekinumab
Cheilitis Granulomatos
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Cheilitis granulomatosa (CG) is a subtype of orofacial granulomatosis that results in facial and oral swelling in the absence of non-caseating granulomatous systemic diseases such as Crohn’s and sarcoidosis.1 With concurrent facial palsy and a plicated tongue, the condition is referred to as Melkersson-Rosenthal syndrome.1,2 Both CG and Melkersson-Rosenthal syndrome are in the …
An Analysis of Skin of Color Publications in the Journal of Drugs in Dermatology
SOC publications
by NEXT STEPS IN DERM TEAM on
INTRODUCTION As the United States population becomes increasingly diverse, it is exceedingly important for dermatologists to be knowledgeable about treating patients with skin of color (SOC). The published literature is an especially valuable resource for treating SOC. Many prevalent dermatological conditions, such as acne vulgaris, atopic dermatitis, and psoriasis, differ histologically and/ …
JDD Issue Highlights | April 2022
psoriasis
by NEXT STEPS IN DERM TEAM on
The April 2022 issue of the Journal of Drugs in Dermatology (JDD) includes the perfect blend of original articles, case reports, and editorials. With topics ranging from injectable fillers, botulinum toxin in hidradenitis suppurativa, cannabis and cannabinoid product use, to psoriasis, melasma, onychomycosis and everything in between, we share this month’s issue highlights straight from the JDD …
Most Patient-Oriented Video Resources Do Not Comprehensively Explain Mohs Micrographic Surgery
Mohs Micrographic Surgery (MMS)
by NEXT STEPS IN DERM TEAM on
INTRODUCTION Mohs micrographic surgery (MMS) is increasingly utilized for treatment of skin cancer, however the technique used is markedly different than other surgical modalities.1,2 Explaining MMS to patients is difficult, and anxiety following a skin cancer diagnosis likely leads many to seek out additional resources to supplement their understanding.3,4 It is unclear how accurate and comp …
Laboratory Testing in Telogen Effluvium
Telogen Effluvium (TE)
by NEXT STEPS IN DERM TEAM on
Telogen effluvium (TE) – a common cause of non- scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. INTRODUCTION Telogen effluvium (TE) – a common cause of non-scarring hair loss – is managed with varying clinical protocols given the paucity of evidence-based practices. While endocrine, vitamin, and mineral abnormalities …